Publishing top research to support the #respiratory & #criticalcare community. Companion #OpenAccess journal, @BMJOpen_Resp. Published with @BTSrespiratory
Weβre making an impact together.
Take a look at the latest journal metrics π Impact Factor and top-cited content. https://t.co/Z9PsV4Lx7L
Behind every published finding is a shared purpose: advancing medical knowledge to improve patient health. #JournalMetrics#BMJGroupImpact
Thorax Editorial: The goal of the tobacco endgame is that no one starts to smoke, that everyone who smokes is supported to quit and that reductions in consumption and profitability mean that the tobacco industry, which continues to be the main barrier to progress, ceases to be commercially viable.
https://t.co/VkjITrAEYm
Calling all researchers in respiratory medicine!
The Lancet Respiratory Medicine and Thorax, in collaboration with the British Thoracic Society, invite you to submit your work for the 2026 BTS Winter Meeting (25β27 November 2026).
Submit your research by 30 June 2026 for a chance to be fast-tracked for publication:
https://t.co/GzLPJD1XC9
The Lancet Respiratory Medicine and Thorax are co-hosting a session with the British Thoracic Society at the 2026 BTS Winter Meeting. Submit your research before 30 June 2026.
Submit your impactful research in respiratory medicine: https://t.co/I7WqWyuhA2
The Lancet Respiratory Medicine, Thorax, and the British Thoracic Society invite you to submit your research for the BTS Winter Meeting (25β27 November 2026).
Submit your high-quality respiratory medicine research by 30 June 2026.
Thorax submissions: https://t.co/I7WqWyuhA2
The SPACE for COPD maintenance programme improved quality of life and was cost-effective when delivered over 12 months. However, the primary outcome, endurance walking time, was not different between control and intervention groups. https://t.co/P7CpLtUTf7 #RespED
Join The Lancet Respiratory Medicine, Thorax, and the British Thoracic Society (BTS) at the 2026 Winter Meeting in London (25β27 November).
We invite submissions of research in respiratory medicine, particularly clinical trials and studies impacting patient care. Selected papers will be fast-tracked for publication.
Submit your research by 30 June 2026.
Submit to Thorax: https://t.co/GzLPJD1XC9
The discrepancy between treated and expected patients with sleep disorders likely represents an underestimation or underdiagnosis of real cases. It remains to be seen to what extent the current dataset will be used to inform the future of sleep healthcare planning in the UK to benefit public health, so that patients do not need to βmind the gapβ https://t.co/i12KJVqwtc
Young children, pregnant women, and immunocompromised people are at the highest risk of severe measles when unvaccinated or unable to respond to immunisation vaccination - roughly one in five unvaccinated people infected by the measles virus will require admission to hospital https://t.co/2wbwan2ToU
Countering health harms from eroded US Environmental Protection Agency "More than a third of health loss from chronic obstructive pulmonary disease is the result of PM air pollution, as are nearly 20% of cardiovascular disease deaths and 32% of preterm births." https://t.co/qF0aAypUq0
"we found that early-childhood growth and neonatal respiratory exposures were associated with lung function at school age, and that spirometric phenotypes identified at ages 6β8 years were associated with distinct longitudinal trajectories through adolescence" https://t.co/lvbsRqlnHL